-
1
-
-
79952288119
-
American Gastroenterological Association. American Gastroenterological Association medical position statement on the management of Barrett's esophagus
-
Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterological Association. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011;140:1084-91.
-
(2011)
Gastroenterology
, vol.140
, pp. 1084-1091
-
-
Spechler, S.J.1
Sharma, P.2
Souza, R.F.3
Inadomi, J.M.4
Shaheen, N.J.5
-
2
-
-
0033180027
-
The incidence of adenocarcinoma and dysplasia in Barrett's esophagus report on the Cleveland Clinic Barrett's esophagus registry
-
DOI 10.1016/S0002-9270(99)00331-7, PII S0002927099003317
-
O'Connor JB, Falk GW, Richter JE. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol 1999;94: 2037-42. (Pubitemid 29374529)
-
(1999)
American Journal of Gastroenterology
, vol.94
, Issue.8
, pp. 2037-2042
-
-
Barry O'Connor, J.1
Falk, G.W.2
Richter, J.E.3
-
3
-
-
0031039244
-
The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years
-
Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92: 212-5. (Pubitemid 27076463)
-
(1997)
American Journal of Gastroenterology
, vol.92
, Issue.2
, pp. 212-215
-
-
Drewitz, D.J.1
Sampliner, R.E.2
Garewal, H.S.3
-
4
-
-
80054010196
-
Incidence of adenocarcinoma among patients with Barrett's esophagus
-
Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011;365:1375-83.
-
(2011)
N Engl J Med
, vol.365
, pp. 1375-1383
-
-
Hvid-Jensen, F.1
Pedersen, L.2
Drewes, A.M.3
Sørensen, H.T.4
Funch-Jensen, P.5
-
5
-
-
0026748207
-
Adenocarcinoma in Barrett's esophagus: A new epidemic?
-
Haggitt RC. Adenocarcinoma in Barrett's esophagus: a new epidemic? Hum Pathol 1992;23:475-6.
-
(1992)
Hum Pathol
, vol.23
, pp. 475-476
-
-
Haggitt, R.C.1
-
6
-
-
0032533670
-
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
-
DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0. CO;2-2
-
Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53. (Pubitemid 28525384)
-
(1998)
Cancer
, vol.83
, Issue.10
, pp. 2049-2053
-
-
Devesa, S.S.1
Blot, W.J.2
Fraumeni Jr., J.F.3
-
7
-
-
0037123288
-
Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: Clinical applications
-
Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applications. JAMA 2002;287: 1982-6. (Pubitemid 34309756)
-
(2002)
Journal of the American Medical Association
, vol.287
, Issue.15
, pp. 1982-1986
-
-
Shaheen, N.1
Ransohoff, D.F.2
-
8
-
-
23044526646
-
'Ome Sweet 'Omics-A Genealogical Treasury of Words
-
Lederberg J, McCray AT. 'Ome sweet 'omics - A genealogical treasury of words. Scientist 2001;15:8. (Pubitemid 33254147)
-
(2001)
Scientist
, vol.15
, Issue.7
, pp. 8
-
-
Lederberg, J.1
McCray, A.T.2
-
9
-
-
62649151803
-
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
-
Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 2009;106: 3698-703.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 3698-3703
-
-
Wikoff, W.R.1
Anfora, A.T.2
Liu, J.3
Schultz, P.G.4
Lesley, S.A.5
Peters, E.C.6
-
10
-
-
67650951420
-
Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome
-
Yang L, Lu X, Nossa CW, Francois F, Peek RM, Pei Z. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 2009;137: 588-97.
-
(2009)
Gastroenterology
, vol.137
, pp. 588-597
-
-
Yang, L.1
Lu, X.2
Nossa, C.W.3
Francois, F.4
Peek, R.M.5
Pei, Z.6
-
11
-
-
75149134769
-
Barrett's oesophagus and oesophageal adenocarcinoma: Time for a new synthesis
-
Reid BJ, Li X, Galipeau PC, Vaughan TL. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer 2010;10:87-101.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 87-101
-
-
Reid, B.J.1
Li, X.2
Galipeau, P.C.3
Vaughan, T.L.4
-
12
-
-
0034292364
-
Cutting edge: Lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappaB
-
Jiang Q, Akashi S, Miyake K, Petty HR. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J Immunol 2000;165: 3541-4. (Pubitemid 32057253)
-
(2000)
Journal of Immunology
, vol.165
, Issue.7
, pp. 3541-3544
-
-
Jiang, Q.1
Akashi, S.2
Miyake, K.3
Petty, H.R.4
-
13
-
-
4644324186
-
NF-kappaB functions as a tumour promoter in inflammation-associated cancer
-
DOI 10.1038/nature02924
-
Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431:461-6. (Pubitemid 39329586)
-
(2004)
Nature
, vol.431
, Issue.7007
, pp. 461-466
-
-
Pikarsky, E.1
Porat, R.M.2
Stein, I.3
Abramovitch, R.4
Amit, S.5
Kasem, S.6
Gutkovich-Pyest, E.7
Uriell-Shoval, S.8
Galun, E.9
Ben-Neriah, Y.10
-
14
-
-
0037090315
-
Regulation of IL-1 receptor-associated kinases by lipopolysaccharide
-
Hu J, Jacinto R, McCall C, Li L. Regulation of IL-1 receptor-associated kinases by lipopolysaccharide. J Immunol 2002;168:3910-4. (Pubitemid 34298394)
-
(2002)
Journal of Immunology
, vol.168
, Issue.8
, pp. 3910-3914
-
-
Hu, J.1
Jacinto, R.2
McCall, C.3
Li, L.4
-
15
-
-
1642334954
-
NF-kappaB Activation in Esophageal Adenocarcinoma: Relationship to Barrett's Metaplasia, Survival, and Response to Neoadjuvant Chemoradiotherapy
-
DOI 10.1097/01.sla.0000118751.95179.c6
-
Abdel-Latif MM, O'Riordan J, Windle HJ, Carton E, Ravi N, Kelleher D, et al. NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg 2004;239:491-500. (Pubitemid 38372765)
-
(2004)
Annals of Surgery
, vol.239
, Issue.4
, pp. 491-500
-
-
Abdel-Latif, M.M.M.1
O'Riordan, J.2
Windle, H.J.3
Carton, E.4
Ravi, N.5
Kelleher, D.6
Reynolds, J.V.7
-
17
-
-
17444445683
-
Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: Clue for the chemoprevention of esophageal carcinoma by antioxidants
-
PII S0027510701001993
-
Lee JS, Oh TY, Ahn BO, Cho H, Kim WB, Kim YB, et al. Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants. Mutat Res 2001;480-481: 189-200. (Pubitemid 32744827)
-
(2001)
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
, vol.480-481
, pp. 189-200
-
-
Lee, J.S.1
Oh, T.Y.2
Ahn, B.O.3
Cho, H.4
Kim, W.B.5
Kim, Y.B.6
Surh, Y.J.7
Kim, H.J.8
Hahm, K.B.9
-
18
-
-
4444382263
-
Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: A possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors
-
DOI 10.1023/B:DDAS.0000037790.11724.70
-
Konturek PC, Nikiforuk A, Kania J, Raithel M, Hahn EG, Mühldorfer S. Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors. Dig Dis Sci 2004;49:1075-83. (Pubitemid 39178068)
-
(2004)
Digestive Diseases and Sciences
, vol.49
, Issue.7-8
, pp. 1075-1083
-
-
Konturek, P.C.1
Nikiforuk, A.2
Kania, J.3
Raithel, M.4
Hahn, E.G.5
Muhldorfer, S.M.6
-
19
-
-
21344432364
-
Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus
-
DOI 10.1111/j.1572-0241.2005.41338.x
-
O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, et al. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Gastroenterol 2005;100:1257-64. (Pubitemid 40904346)
-
(2005)
American Journal of Gastroenterology
, vol.100
, Issue.6
, pp. 1257-1264
-
-
O'Riordan, J.M.1
Abdel-Latif, M.M.2
Ravi, N.3
McNamara, D.4
Byrne, P.J.5
McDonald, G.S.A.6
Keeling, P.W.N.7
Kelleher, D.8
Reynolds, J.V.9
-
20
-
-
63649137892
-
Potential role of NF-kappaB in esophageal adenocarcinoma: As an emerging molecular target
-
Abdel-Latif MMM, Kelleher D, Reynolds JV. Potential role of NF-kappaB in esophageal adenocarcinoma: as an emerging molecular target. J Surg Res 2009;153:172-80.
-
(2009)
J Surg Res
, vol.153
, pp. 172-180
-
-
Abdel-Latif, M.M.M.1
Kelleher, D.2
Reynolds, J.V.3
-
21
-
-
79952773453
-
Modulation of NF-kB signalling by microbial pathogens
-
Rahman MM, McFadden G. Modulation of NF-kB signalling by microbial pathogens. Nat Rev Microbiol 2011;9:291-306.
-
(2011)
Nat Rev Microbiol
, vol.9
, pp. 291-306
-
-
Rahman, M.M.1
McFadden, G.2
-
22
-
-
14044268789
-
Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae
-
Opitz B, Förster S, Hocke AC, Maass M, Schmeck B, Hippenstiel S, et al. Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae. Circ Res 2005;96:319-26.
-
(2005)
Circ Res
, vol.96
, pp. 319-326
-
-
Opitz, B.1
Förster, S.2
Hocke, A.C.3
Maass, M.4
Schmeck, B.5
Hippenstiel, S.6
-
23
-
-
9244245293
-
Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
-
DOI 10.1038/ni1131
-
Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004;5:1166-74. (Pubitemid 39549631)
-
(2004)
Nature Immunology
, vol.5
, Issue.11
, pp. 1166-1174
-
-
Viala, J.1
Chaput, C.2
Boneca, I.G.3
Cardona, A.4
Girardin, S.E.5
Moran, A.P.6
Athman, R.7
Memet, S.8
Huerre, M.R.9
Coyle, A.J.10
DiStefano, P.S.11
Sansonetti, P.J.12
Labigne, A.13
Bertin, J.14
Philpott, D.J.15
Ferrero, R.L.16
-
24
-
-
0035978651
-
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
-
DOI 10.1038/35079107
-
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603. (Pubitemid 32531408)
-
(2001)
Nature
, vol.411
, Issue.6837
, pp. 599-603
-
-
Hugot, J.-P.1
Chamaillard, M.2
Zouali, H.3
Lesage, S.4
Cezard, J.-P.5
Belaiche, J.6
Almer, S.7
Tysk, C.8
O'morain, C.A.9
Gassull, M.10
Binder, V.11
Finkel, Y.12
Cortot, A.13
Modigliani, R.14
Laurent-Puig, P.15
Gower-Rousseau, C.16
Macry, J.17
Colombel, J.-F.18
Sahbatou, M.19
Thomas, G.20
more..
-
25
-
-
0035978533
-
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
-
DOI 10.1038/35079114
-
Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6. (Pubitemid 32531409)
-
(2001)
Nature
, vol.411
, Issue.6837
, pp. 603-606
-
-
Ogura, Y.1
Bonen, D.K.2
Inohara, N.3
Nicolae, D.L.4
Chen, F.F.5
Ramos, R.6
Britton, H.7
Moran, T.8
Karaliuskas, R.9
Duerr, R.H.10
Achkar, J.-P.11
Brant, S.R.12
Bayless, T.M.13
Kirschner, B.S.14
Hanauer, S.B.15
Nuez, G.16
Cho, J.H.17
-
26
-
-
33244472793
-
Signalling pathways and molecular interactions of NOD1 and NOD2
-
DOI 10.1038/nri1747, PII N1747
-
Strober W, Murray PJ, Kitani A, Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol 2006; 6:9-20. (Pubitemid 43279749)
-
(2006)
Nature Reviews Immunology
, vol.6
, Issue.1
, pp. 9-20
-
-
Strober, W.1
Murray, P.J.2
Kitani, A.3
Watanabe, T.4
-
28
-
-
80053908650
-
Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma
-
Sheyhidin I, Nabi G, Hasim A, Zhang RP, Ainiwaer J, Ma H, et al. Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma. World J Gastroenterol 2011;17:3745-51.
-
(2011)
World J Gastroenterol
, vol.17
, pp. 3745-3751
-
-
Sheyhidin, I.1
Nabi, G.2
Hasim, A.3
Zhang, R.P.4
Ainiwaer, J.5
Ma, H.6
-
29
-
-
0036278756
-
Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: Immunological determinants
-
DOI 10.1136/gut.50.4.451
-
Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, Saeed IT, Burnham WR, Farthing MJ. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut 2002;50:451-9. (Pubitemid 34638860)
-
(2002)
Gut
, vol.50
, Issue.4
, pp. 451-459
-
-
Fitzgerald, R.C.1
Onwuegbusi, B.A.2
Bajaj-Elliott, M.3
Saeed, I.T.4
Burnham, W.R.5
Farthing, M.J.G.6
-
30
-
-
0034102269
-
Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
-
Shirvani VN, Ouatu-Lascar R, Kaur BS, Omary MB, Triadafilopoulos G. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. Gastroenterology 2000;118:487-96. (Pubitemid 30140846)
-
(2000)
Gastroenterology
, vol.118
, Issue.3
, pp. 487-496
-
-
Shirvani, V.N.1
Ouatu-Lascar, R.2
Kaur, B.S.3
Omary, M.B.4
Triadafilopoulos, G.5
-
31
-
-
0035045145
-
Cyclooxygenase-2 expression in the barrett's metaplasia-dysplasia- adenocarcinoma sequence
-
DOI 10.1016/S0002-9270(00)02392-3, PII S0002927000023923
-
Morris CD, Armstrong GR, Bigley G, Green H, Attwood SE. Cyclooxygenase- 2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Am J Gastroenterol 2001;96:990-6. (Pubitemid 32319127)
-
(2001)
American Journal of Gastroenterology
, vol.96
, Issue.4
, pp. 990-996
-
-
Morris, C.D.1
Armstrong, G.R.2
Bigley, G.3
Green, H.4
Attwood, S.E.A.5
-
32
-
-
0032528178
-
Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas
-
Wilson KT, Fu S, Ramanujam KS, Meltzer SJ. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 1998;58: 2929-34. (Pubitemid 28335064)
-
(1998)
Cancer Research
, vol.58
, Issue.14
, pp. 2929-2934
-
-
Wilson, K.T.1
Fu, S.2
Ramanujam, K.S.3
Meltzer, S.J.4
-
33
-
-
0036083347
-
Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus
-
Buskens CJ, Van Rees BP, Sivula A, Reitsma JB, Haglund C, Bosma PJ, et al. Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology 2002;122:1800-7. (Pubitemid 34651424)
-
(2002)
Gastroenterology
, vol.122
, Issue.7
, pp. 1800-1807
-
-
Buskens, C.J.1
Van Rees, B.P.2
Sivula, A.3
Reitsma, J.B.4
Haglund, C.5
Bosma, P.J.6
Offerhaus, G.JohanA.7
Van Lanschot, J.Janb.8
Ristimaki, A.9
-
34
-
-
0035023868
-
Inducible and neuronal nitric oxide synthase involvement in lipopolysaccharide-induced sphincteric dysfunction
-
Fan YP, Chakder S, Gao F, Rattan S. Inducible and neuronal nitric oxide synthase involvement in lipopolysaccharide-induced sphincteric dysfunction. Am J Physiol Gastrointest Liver Physiol 2001;280: G32-42.
-
(2001)
Am J Physiol Gastrointest Liver Physiol
, vol.280
-
-
Fan, Y.P.1
Chakder, S.2
Gao, F.3
Rattan, S.4
-
35
-
-
70349330655
-
Frequency of single nucleotide polymorphisms inNOD1gene of ulcerative colitis patients: A case-control study in the Indian population
-
Verma R, Ahuja V, Paul J. Frequency of single nucleotide polymorphisms inNOD1gene of ulcerative colitis patients: a case-control study in the Indian population. BMC Med Genet 2009;10:82.
-
(2009)
BMC Med Genet
, vol.10
, pp. 82
-
-
Verma, R.1
Ahuja, V.2
Paul, J.3
-
37
-
-
67749117934
-
Signal integration by JNK and p38 MAPK pathways in cancer development
-
Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009;9: 537-49.
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 537-549
-
-
Wagner, E.F.1
Nebreda, A.R.2
-
38
-
-
0036889770
-
Downregulation of nNOS and synthesis of PGs associated with endotoxin-induced delay in gastric emptying
-
Calatayud S, García-Zaragozá E, Hernández C, Quintana E, Felipo V, Esplugues JV, et al. Downregulation of nNOS and synthesis of PGs associated with endotoxin-induced delay in gastric emptying. Am J Physiol Gastrointest Liver Physiol 2002;283:G1360-7. (Pubitemid 35351124)
-
(2002)
American Journal of Physiology - Gastrointestinal and Liver Physiology
, vol.283
, Issue.6
-
-
Calatayud, S.1
Garcia-Zaragoza, E.2
Hernandez, C.3
Quintana, E.4
Felipo, V.5
Esplugues, J.V.6
Barrachina, M.D.7
-
39
-
-
53949090765
-
NF-kappaB signaling pathway and its therapeutic implications in human diseases
-
Sarkar FH, Li Y, Wang Z, Kong D. NF-kappaB signaling pathway and its therapeutic implications in human diseases. Int Rev Immunol 2008;27: 293-319.
-
(2008)
Int Rev Immunol
, vol.27
, pp. 293-319
-
-
Sarkar, F.H.1
Li, Y.2
Wang, Z.3
Kong, D.4
-
40
-
-
33847188791
-
NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer
-
Calzado MA, Bacher S, Schmitz ML. NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer. Curr Med Chem 2007;14:367-76.
-
(2007)
Curr Med Chem
, vol.14
, pp. 367-376
-
-
Calzado, M.A.1
Bacher, S.2
Schmitz, M.L.3
-
41
-
-
0035139792
-
Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer
-
Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001;107:135-42. (Pubitemid 32096826)
-
(2001)
Journal of Clinical Investigation
, vol.107
, Issue.2
, pp. 135-142
-
-
Yamamoto, Y.1
Gaynor, R.B.2
-
42
-
-
77953473219
-
Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma
-
Hartojo W, Silvers AL, Thomas DG, Seder CW, Lin L, Rao H, et al. Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma. Transl Oncol 2010;3:99-108.
-
(2010)
Transl Oncol
, vol.3
, pp. 99-108
-
-
Hartojo, W.1
Silvers, A.L.2
Thomas, D.G.3
Seder, C.W.4
Lin, L.5
Rao, H.6
-
43
-
-
77958096472
-
Inducible nitric oxide synthase (iNOS) gene polymorphism and disease prevalence
-
Qidwai T, Jamal F. Inducible nitric oxide synthase (iNOS) gene polymorphism and disease prevalence. Scand J Immunol 2010;72: 375-87.
-
(2010)
Scand J Immunol
, vol.72
, pp. 375-387
-
-
Qidwai, T.1
Jamal, F.2
-
45
-
-
27744596081
-
Nitric oxide-modulating agents for gastrointestinal disorders
-
Whittle BJ. Nitric oxide-modulating agents for gastrointestinal disorders. Expert Opin Investig Drugs 2005;14:1347-58.
-
(2005)
Expert Opin Investig Drugs
, vol.14
, pp. 1347-1358
-
-
Whittle, B.J.1
-
46
-
-
70349308062
-
Inhibition of inducible nitric oxide synthase in respiratory diseases
-
Hesslinger C, Strub A, Boer R, Ulrich WR, Lehner MD, Braun C. Inhibition of inducible nitric oxide synthase in respiratory diseases. Biochem Soc Trans 2009;37:886-91.
-
(2009)
Biochem Soc Trans
, vol.37
, pp. 886-891
-
-
Hesslinger, C.1
Strub, A.2
Boer, R.3
Ulrich, W.R.4
Lehner, M.D.5
Braun, C.6
-
47
-
-
33746486791
-
Role of non-protein amino acid l-canavanine in autoimmunity
-
DOI 10.1016/j.autrev.2005.12.004, PII S1568997205002223
-
Akaogi J, Barker T, Kuroda Y, Nacionales DC, Yamasaki Y, Stevens BR, et al. Role of non-protein amino acid L-canavanine in autoimmunity. Autoimmun Rev 2006;5:429-35. (Pubitemid 44143038)
-
(2006)
Autoimmunity Reviews
, vol.5
, Issue.6
, pp. 429-435
-
-
Akaogi, J.1
Barker, T.2
Kuroda, Y.3
Nacionales, D.C.4
Yamasaki, Y.5
Stevens, B.R.6
Reeves, W.H.7
Satoh, M.8
-
48
-
-
0038604348
-
Aselective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics
-
Hansel TT, Kharitonov SA, Donnelly LE, Erin EM, Currie MG, Moore WM,et al. Aselective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J 2003;17:1298-300.
-
(2003)
FASEB J
, vol.17
, pp. 1298-1300
-
-
Hansel, T.T.1
Kharitonov, S.A.2
Donnelly, L.E.3
Erin, E.M.4
Currie, M.G.5
Moore, W.M.6
-
49
-
-
0037219463
-
Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis
-
DOI 10.1053/gast.2003.50008
-
Corley DA, Kerlikowske K, Verma R, Buffler P. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 2003;124: 47-56. (Pubitemid 36055338)
-
(2003)
Gastroenterology
, vol.124
, Issue.1
, pp. 47-56
-
-
Corley, D.A.1
Kerlikowse, K.2
Verma, R.3
Buffler, P.4
-
50
-
-
77952837521
-
Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus
-
Nguyen DM, Richardson P, El-Serag HB. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology 2010; 138:2260-6.
-
(2010)
Gastroenterology
, vol.138
, pp. 2260-2266
-
-
Nguyen, D.M.1
Richardson, P.2
El-Serag, H.B.3
-
51
-
-
81855167480
-
Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus
-
Kastelein F, Spaander MC, Biermann K, Steyerberg EW, Kuipers EJ, Bruno MJ. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus. Gastroenterology 2011;141:2000-8.
-
(2011)
Gastroenterology
, vol.141
, pp. 2000-2008
-
-
Kastelein, F.1
Spaander, M.C.2
Biermann, K.3
Steyerberg, E.W.4
Kuipers, E.J.5
Bruno, M.J.6
|